About Koye
Koye is a Healthcare company based in Mumbai (India) founded in 2013 by Ravindra Yogesh Shenoy and Preetish Toraskar. Essential drugs for primary specialty care are manufactured. Koye has raised $46.86 million across 8 funding rounds from investors including BlackSoil, Peak XV Partners and InnoVen Capital. The company has 673 employees. Koye was last valued at $96.64 million in March 2017. Its Indian entity Koye Pharmaceuticals Private Limited reported revenue of ₹129 Cr. Koye offers products and services including Health Products and Wellness Services. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Koye was established in 2013 in Mumbai, India, within the pharmaceutical sector. Essential drugs targeting ailments such as arthritis, iron deficiency, and asthma are produced for primary specialty care. Healthcare solutions recommended by physicians, referred by patients, and chosen by partners are provided. Investments from existing and new investors are currently being sought to support operations.
- Headquarters Mumbai, India
- Employees 673
- Founders Ravindra Yogesh Shenoy, Preetish Toraskar
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website koye.co
- Social LinkedIn X Facebook
- Legal Name Koye Pharmaceuticals Pvt Ltd
- Date of Incorporation 12 May, 2013
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹129 Cr
FY 2025 · -4% YoY
- Net Loss-₹12.28 Cr
FY 2025 · -10% margin
- EBITDA₹29.43 Cr
FY 2025 · 23% margin
- Total Equity Funding$46.86M (USD)
in 8 rounds
- Latest Funding Round$4.11M (USD), Debt – Conventional
Sep 2020
- InvestorsBlackSoil
& 3 more
- Employee Count673
Associated legal entities of Koye
Koye operates through Koye Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Koye Pharmaceuticals Private Limited CIN U74120MH2013PTC243214 | Active | 12 May 2013 | Mumbai, Maharashtra | ₹129 Cr | 673 | 5 | View details |
Products & Services of Koye
Koye offers a comprehensive portfolio of products and services, including Health Products and Wellness Services.
Pharmaceutical products are developed and distributed to promote healthiness and happiness.
Services aimed at pursuing healthiness are offered through wellness initiatives.
Funding Insights of Koye
Koye has successfully raised a total of $46.86M across 8 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $4.11 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $46.86M
- Total Rounds 8
- Last Round Debt – Conventional — $4.11M
- First Round $3.67M
(Oct 2013)
- Investors Count 4
All 8 funding rounds of Koye with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2020 | $4.11M | Debt – Conventional | – | – | |
| Jul 2018 | $17.99M | Series C | – | Premji Invest | – |
| Mar 2017 | $8.46M | Series B | $96.64M | Peak XV Partners | – |
| Aug 2016 | $5.99M | Series A | $97.82M | Peak XV Partners | – |
| Jul 2016 | Debt – Venture | – | – | ||
| Mar 2015 | $9.56M | Series A | $••••• | Peak XV Partners | – |
| Dec 2014 | $1.18M | Seed | $••••• | Peak XV Partners | – |
| Oct 2013 | $3.67M | Seed | $••••• | Peak XV Partners | – |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2017 | $96.64M | •••••••• |
| Aug 2016 | $97.82M | •••••••• |
| Mar 2015 | $••••• | •••••••• |
| Dec 2014 | $••••• | •••••••• |
| Oct 2013 | $••••• | •••••••• |
Full valuation and stage history of Koye
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $96.64M (Mar 2017). 4 investors in total: 4 institutional.
Investors in Koye
Koye has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include BlackSoil, Peak XV Partners and InnoVen Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provides venture capital for technology startups and enterprise innovations worldwide. | premjiinvest.com | Bengaluru, India | ||
Venture capital firm investing in startups and providing support programs. | 2000 | peakxv.com | Bengaluru, India | |
Venture debt financing is extended to companies across multiple sectors. | 2008 | innovencapital.com | Mumbai, India | |
Private debt is provided to growth-stage companies by BlackSoil. | 2010 | blacksoil.co.in | Mumbai, India |
Investor details for Koye
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Koye Pharmaceuticals Private Limited (Koye)
Koye Pharmaceuticals Private Limited is the primary company behind Koye. The board of Koye Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Ravindra Yogesh Shenoy, appointed in 2013. 12 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ravindra Yogesh Shenoy DIN 00410124 | Director | 16 Jul 2013 | 13 yrs 3 mo | Koye Pharmaceuticals Private Limited |
| Preetish Mohan Toraskar DIN 05299763 | Director | 09 Sep 2013 | 13 yrs 1 mo | Koye Pharmaceuticals Private Limited |
| Vishal Kaushik DIN 11246169 | Director | 27 Aug 2025 | 1 yr 2 mo | Koye Pharmaceuticals Private Limited |
People of Koye
12 people are tracked at Koye (5 in leadership, 7 in team); the tracked headcount is 673.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
Surjit Hota | Assistant General Manager- Sales | Leadership |
Anandeep Chadha | Head Of Finance | Leadership |
Ashu Gupta | Vice President Supply Chain Management | Leadership |
Manish Pal | Business Professional | Team |
Mudasir Wani | Business Manager | Team |
Vijay Vaishnav | Business Development Manager | Team |
Yadvendrapati Tripathi | DGM Sales | Team |
Sachin Prabhudesai | Manager, Production Planning & Outsourcing | Team |
Ronak Kariya | Regional Manager | Team |
Milapsingh Heero | Global Brands | Team |
Complete people profiles for Koye
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Koye
Figures of Koye Pharmaceuticals Private Limited, the primary company behind Koye, for FY 2025. Revenue was ₹129 Cr (-4% year on year). Net loss was -₹12.28 Cr (-10% margin). EBITDA was ₹29.43 Cr (23% margin). Revenue has grown at a compounded annual rate of -25% over three years and -13% over five years.
- ₹129 CrRevenue · FY 2025 · -4% YoY
- -₹12.28 CrNet loss · -10% margin
- ₹29.43 CrEBITDA · 23% margin
- ₹21.17 CrPaid-up capital
- 673Employees (provident fund records)
- -25%Revenue CAGR, 3 years
- -13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Koye Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Koye
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Koye
4 dated milestones of Koye across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Koye is founded.
- Funding First funding round of $3.7M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Debt – Conventional, of $4.1M.
Web traffic of Koye
The website of Koye (koye.co) receives about 6.3K visits a month.
- Monthly visits6.3K
▲ 433.7% vs previous month
Websites whose visitors overlap most with Koye. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| macleodspharma.com | 100% | 23.3K | #522,868 | View details | |
| raysahelian.com | 89% | View details | |||
| meherdistributors.com | 71% | 111.7K | #277,055 | View details | |
icewarpcloud.in | icewarpcloud.in | 29% | #126,894 | – |
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Koye (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 5,180 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.21 B | 25,870 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Koye
Complete news archive for Koye
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Koye
Koye was founded in 2013.
Koye is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Koye is a funded company, having raised a total of $46.86M across 8 funding rounds to date. The company's 1st funding round was a Seed of $3.67M, raised on Oct 2013.
Koye has 673 employees.
The primary company behind Koye, Koye Pharmaceuticals Private Limited, reported revenue of ₹129 Cr for FY 2025, down 4% year on year.
Koye was established in 2013 in Mumbai, India, within the pharmaceutical sector. Essential drugs targeting ailments such as arthritis, iron deficiency, and asthma are produced for primary specialty care. Healthcare solutions recommended by physicians, referred by patients, and chosen by partners are provided. Investments from existing and new investors are currently being sought to support operations.
Koye offers Health Products and Wellness Services.
Koye has 4 investors. Key investors include BlackSoil, Peak XV Partners, InnoVen Capital, and Premji Invest.
The valuation of Koye is $96.64M as of Mar 2017.
Koye operates through Koye Pharmaceuticals Private Limited.
The legal entities of Koye currently have 5 directors, including Ravindra Yogesh Shenoy, Preetish Mohan Toraskar, Mitali Mukund Kulkarni and others.